Compound heterozygosity for a novel nine-nucleotide deletion and the Asn45Ser missense mutation in the glycoprotein IX gene in a patient with Bernard-Soulier syndrome

Am J Hematol. 2005 Jan;78(1):41-8. doi: 10.1002/ajh.20236.

Abstract

Bernard-Soulier syndrome (BSS) is a rare inherited bleeding disorder due to quantitative or qualitative abnormalities in the platelet glycoprotein (GP) Ib/IX/V complex, the major von Willebrand factor receptor. The complex comprises four subunits, each encoded by a separate gene. Several mutations have been described for each of the subunits, except for GPV, as a cause of BSS. We describe here the genetic basis of the disorder in a child with BSS. Flow-cytometric analysis of the patient's platelets showed a markedly reduced surface expression of all three glycoproteins of the GPIb/IX/V complex. DNA sequencing analysis showed the patient to be a compound heterozygote for two mutations in the GPIX gene, a novel nine-nucleotide deletion starting at position 1952 of the gene that changes asparagine 86 for alanine and eliminates amino acids 87, 88, and 89 (arginine, threonine, and proline) and a previously reported point mutation that changes the codon asparagine (AAC) for serine (AGC) at residue 45. Her mother was heterozygous for the Asn45Ser mutation, and her father, for the nine-nucleotide deletion. Our findings suggest that the additive effects of both mutations in the GPIX gene are responsible for the BSS phenotype of the patient.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asparagine
  • Base Sequence
  • Bernard-Soulier Syndrome / genetics*
  • Bernard-Soulier Syndrome / metabolism
  • Child
  • DNA / genetics
  • Female
  • Flow Cytometry
  • Gene Deletion*
  • Heterozygote*
  • Humans
  • Mutation, Missense*
  • Platelet Glycoprotein GPIb-IX Complex / genetics*
  • Platelet Glycoprotein GPIb-IX Complex / metabolism
  • Serine

Substances

  • Platelet Glycoprotein GPIb-IX Complex
  • Serine
  • Asparagine
  • DNA